634 results about "Corynebacterium glutamicum" patented technology

The invention discloses construction and application of a CRISPR/Cas9 gene editing vector for microorganisms. The constructed CRISPR/Cas9 gene vector consists of a replication start site, a selection marker gene, a Cas9 protein gene, gRNA coding DNA, a homologous recombinant element and an operon. The CRISPR/Cas9 gene vector constructed by the invention is capable of editing (including performing such operations as knocking out, replacing, interpolating and the like on gene or DNA sequence) escherichia coli or corynebacterium glutamicum genome; and the gene vector has the advantages of being short in test cycle, time-saving and cost-saving, high in efficiency and the like.

A process for preparing the multi-vitamine multi-enzyme high-protein microbial preparation by the solid fermentation of multiple bacterial strains includes such steps as preparing seed culture media, respectively inoculating reticularia, torula yeast, glutamic corynebacteria, Bacillus subtitis, Aspergillus niger, etc into said seed culture media, culturing at 30-35 deg.C for 15-18 hr, inoculating them into the solid culture medium, fermenting at 33+/-0.5 deg.C for 70-80 hr, and fast drying. Its can be used as the feed containing living microbes, microbial enzymes, vitamines, etc.

The invention relates to a genetically engineered bacterium producing tetrahydropyrimidine and a structuring method and application thereof. The genetically engineered bacterium is Escherichia coli with a specific genotype, comprises Halomonas-elogata-derived ectABC gene, has three gene deficiency variants including lysA, thrA and iclR and has corynebacterium glutamicum lysC gene controlled by a lac promoter and ppc gene controlled by a trc promoter. The defect that chemical synthesis methods have harsh reaction conditions and high energy consumption can be overcome by using the genetically engineered bacterium and utilizing glucose fermentation to produce tetrahydropyrimidine. The defect that Halomonas-elogata fermentation or enzyme-catalyzed methods are complex in process and high in production cost can be overcome. After fermentation for 20-28h, yield of tetrahydropyrimidine reaches 12-18g/L, and the genetically engineered bacterium has high industrial application value.

The invention relates to a cadaverine-producing engineering strain, a construction method thereof and a method for producing cadaverine by using the strain. Based on a gene engineering technology, an L-lysine decarboxylase gene (cadA/LDC) and a cadaverine-lysine antiporter gene (cadB) are respectively or simultaneously cloned into Corynebacterium glutamicum and subjected to induced coexpression, the lysine is decarboxylated to generate cadaverine under the catalytic action of the CadA enzyme, and the cadaverine is transported out of cells by the CadB protein, thus constructing a high-yield cadaverine-producing engineering strain and establishing a novel one-step cadaverine synthesis method based on the fermentation of Corynebacterium glutamicum. The one-step cadaverine synthesis method based on microbial fermentation provides a new way for large-scale cadaverine production, thereby having great economic benefits and social benefits and wide market development prospects.

The object of the present invention is to provide a method of producing a heterologous protein by making a coryneform bacterium to produce and efficiently extracellularly secrete (secreto-production) an industrially useful heterologous protein. According to the present invention, a genetic construct is used where a gene sequence encoding an intended protein which is ligated to the downstream of a sequence encoding the signal peptide derived from a coryneform bacterium, the gene construct is introduced into a mutant coryneform bacterium which has a capacity of secreting the heterologous protein at least 2-fold higher than the wild type Corynebacterium glutamicum ATCC 13869, the mutant coryneform bacterium is cultured and the extracellularly released heterologous protein is recovered.

Isolated nucleic acid molecules, designated PTS nucleic acid molecules, which encode novel PTS proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PTS nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated PTS proteins, mutated PTS proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of PTS genes in this organism.

Isolated nucleic acid molecules, designated MCT nucleic acid molecules, which encode novel MCT proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MCT nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated MCT proteins, mutated MCT proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of MCT genes in this organism.

The invention relates to a method for coupled production of cadaverine by using microbial fermentation and microbial conversion. By use of the gene engineering technology, lysine decarboxylase genes with different sources are cloned in Escherichia coli or corynebacterium glutamicum with high yield of lysine for secretory expression, recombinant stains are fermented, the recombinant strains synthesize lysine at the first stage, lysine decarboxylase genes are induced for secretory expression at the second stage, and the lysine is converted into the cadaverine. The method for coupled production of cadaverine by using microbial fermentation and microbial conversion provides a new way for production of the cadaverine, has enormous economic benefit and social benefit and has broad market development prospect.

The invention discloses a comprehensive method for extracting L-tryptophan from fermentation liquor. The L-tryptophan is extracted from fermentation liquor which is made from corynebacterium glutmicum as a strain; meanwhile, generated waste liquor is recycled. The comprehensive method comprises the steps of: extracting the L-tryptophan and recycling the waste liquor, wherein the waste liquor generated in an extraction process is treated or recycled for application or used for preparing a compound fertilizer, a feed additive and feed protein. The method completely, effectively and comprehensively utilizes resources, recycles the generated waste liquor while extracting the L-tryptophan, reduces the resource waste, basically realizes the zero emission of waste water, effectively recycles the resources, and lightens the environment-protecting pressure.

The invention discloses a method of producing a protein feed by a liquid-solid two-step fermentation method. The method comprises the following steps: performing liquid culture on corynebacterium glutamicum, candida utilis, bacillus subtilis, lactobacillus plantarum and aspergillus oryzae so as to obtain corynebacterium glutamicum fermentation liquor, candida utilis fermentation liquor, bacillus subtilis fermentation liquor, lactobacillus plantarum fermentation liquor and aspergillus oryzae fermentation liquor; mixing the corynebacterium glutamicum fermentation liquor, the candida utilis fermentation liquor, the bacillus subtilis fermentation liquor, the lactobacillus plantarum fermentation liquor and the aspergillus oryzae fermentation liquor so as to obtain mixed bacterium liquor; loading raw materials of soybean meal, cluster bean meal, cottonseed meal and the like into an explosion vat for performing steam explosion; after steam explosion, mixing materials, the mixed bacterium liquor and molasses in proportion, and adding an enzyme preparation so as to obtain mixed materials; conveying the mixed materials into a special modularized solid-state biological raw material continuous fermentation device for enzymolysis and fermentation, and drying the fermented materials so as to obtain the protein feed. According to the method disclosed by the invention, the modularized automatic fermentation device is adopted, the materials after explosion, the fermented bacterium liquor and the enzyme preparation are mixed, then the mixed materials are loaded into the automatic fermentation device for enzymolysis and biological fermentation, so that requirements for automatic temperature control, automatic dampness control and automatic ventilation control are met, the bioconversion rate is high, the fermentation period is short, the consumption is low, the cost is low, and mechanized and large-scale production requirements can be met.

The invention discloses L-isoleucine producing genetically engineered bacteria and a construction method and application thereof, belonging to the technical field of genetic engineering and microbial fermentation. According to the method, a knockout vector of the gene alr is constructed and electroporated into the host bacteria to obtain a deficient strain IWJ001 delta alr of the alr. The gene segments are connected to an overexpression vector by use of the PCR amplification genes fusA, frr, ilvBN, ilvA and ippnk and then electroporated into corynebacterium glutamicum IWJ001 delta alr, and the target genetically engineered bacteria, namely L-isoleucine producing genetically engineered bacteria IWJ001 delta alr/pJYW-4-fusA-frr-ilvBN-ilvA-ppnk, are obtained through antibiotic resistance screening. The L-isoleucine producing genetically engineered bacteria constructed by the method disclosed by the invention can be used for increasing the yield of L-isoleucine through fermentation in a shake flask or fermentation tank, and the method is conductive to reducing the difficulty in separation and purification and increasing the yield so as to remarkably reduce the production cost of L-isoleucine.

The invention discloses construction of a strain of corynebacterium glutamicum engineering bacteria for high-yielding production of L-valine and a method for fermentation production of L-valine, and belongs to the technical field of food biological engineering. Corynebacterium glutamicum ATCC13869 is used as an original bacterial strain, knockout combination of genes of aceE, alaT and ilvA is carried out, and an ATCC13869[delta]aceE[delta]alaT[delta]ilvA mutant bacterial strain is obtained and named as WCC003; expression combination of genes of lrp1, brnFE and ilvBNC1 is carried out on the WCC003, and expression-combined engineering bacteria WCC003/pJYW-4-(ilvBNC1)-lrp1-brnFE are obtained and preserved in China center for type culture collection with the preservation number of CCTCC NO:M2014149; the expression-combined engineering bacteria are used for fermentation production of L-valine. The corynebacterium glutamicum engineering bacteria based on the expression regulating protein Lrp, the transfer protein BrnFE and the L-valine synthetic route key gene ilvBNC1 and used for high-yielding production of L-valine are provided, advantageous mutation Arg39Trp of Lrp in corynebacterium glutamicum is clear and definite for the first time, a fact that Lrp and BrnFE are used for fermentation production of L-valine is also reported for the first time, and the study on the expression combination of the genes of lrp1, brnFE and ilvBNC1 is also created for the first time.

The invention relates to the technical field of biological engineering, in particular to a strain for producing L-leucine and a method for producing the L-leucine. According to the method, corynebacterium glutamicum is induced by using ultraviolet rays and nitrosoguanidine, then key mutants leuAG561D and ilvBG235S which are beneficial to generation of the L-leucine can be generated, research shows that under mutation conditions of leuAG561D and/or ilvBG235S, feedback inhibition of synthesis routes of the L-leucine can be released, the yield of the L-leucine can be greatly increased, a strain which can generate a great deal of the L-leucine can be obtained, the preservation number of the strain is CGMCC NO.13408, the strain is capable of achieving efficient accumulation of the L-leucine in the fermentation process, and the L-leucine can be up to 4.7g/L.

The invention relates to a mutant of trehalose synthetase from corynebacterium glutamicum. A method for obtaining the mutant performs site-directed saturation mutation on a phenylalanine residue at the 263rd site of an amino acid sequence of trehalose synthetase from corynebacterium glutamicum by using a site-directed mutation technology, and the method for obtaining the mutant also comprises the following step: the saturation mutation is performed on at least one amino acid residue in at least 80 percent of homologous trehalose synthetase sequences of an amino acid sequence including SEQ ID NO.1, SEQID NO.2, SEQ ID NO.3 and SEQ ID NO.4. The reaction kinetics of the trehalose synthetase expressed by a mutated trehalose synthetase gene changes, various enzymology characteristics such as specific activity of enzyme, optimum reaction temperature, optimum pH value, and the like also change, and the enzyme can improve the transformation efficiency of the trehalose synthetase and further reduce the production cost of the trehalose.

The invention relates to a genetically engineered bacterium for high-yield production of hydroxytetrahydropyrimidine as well as a construction method and application of the genetically engineered bacterium. The strain integrates RNA (Ribonucleic Acid) polymerase which is controlled by a xylose promoter and is derived from T7 bacteriophage; a thrA gene for encoding homoserine dehydrogenase I is knocked out; a lysC gene derived from corynebacterium glutamicum, an ectABC gene cluster derived from halomonas elongate and an ectD gene for encoding tetrahydropyrimidine hydroxylase are integrated andare promoted by a strong promoter PT7; a hydroxytetrahydropyrimidine synthesis way is reconstructed; the ectD gene is integrated at a sucCD site of succinyl coenzyme A synthetase and is started by thestrong promoter PT7; the genetically engineered bacterium has the highest level of producing the hydroxytetrahydropyrimidine by a fermentation method which is reported at present.

Belonging to the technical field of bioengineering, the invention relates to corynebacterium glutamicum and a production method of alpha-ketoglutarate through fermentation of corynebacterium glutamicum. The bacterial strain of the invention is corynebacterium glutamicum GKG-047, with a preservation number of CGMCC No. 5481. With a strain of glutamic acid producing strain GDK-9 as a parent, the bacterial strain of the invention is a mutant strain that is screened out through mutagenesis and sensitive to methotrexate. Under the circumstance of a limited nitrogen source supply, the bacterial strain can accumulate alpha-ketoglutarate. During fermentation, the bacterial strain is characterized by aerobic fermentation, fast bacterium growth, and rapid acid production rate. After fermentation of the bacterial strain for 32h in a fermentation tank of 10L, the maximum output of alpha-ketoglutarate can be 47.2g/L. The method provided in the invention has the advantages of simple and easily controllable fermentation process, and low production cost of alpha-ketoglutarate, thus being in favor of the popularization and application of industrial production.

The invention discloses a high yield L-leucine engineering bacterium and an application of the bacterium.The invention provides a method for preparing a recombinant bacterium. The method comprises the following step of importing an alpha-isopropylmolic acid synthetase mutant encoding gene into a target bacterium to form the recombinant bacterium, wherein an alpha-isopropylmolic acid synthetase mutant is enzyme obtained by mutating 494th arginine of alpha-isopropylmolic acid synthetase into histidine, 497th glycine into aspartic acid and 499th leucine into valine.The high yield L- leucine engineering bacterium, particularly corynebacterium glutamicum MD0032, has higher L-leucine yield than bacterial strains produced at home at present, has a unique identification label and is a L-leucine production strain with a high production and application value.

The invention discloses a promoter with a nucleotide sequence as follows: 1) a nucleotide sequence shown in sequence 1 in a sequence table; 2) a nucleotide sequence which hybridizes with the nucleotide sequence in 1) under strict conditions and has promoter activity; or 3) a nucleotide sequence which has homology of more than 70% with the nucleotide sequence in 1) and has promoter activity. The promoter provided by the invention can be applied to the biotechnology field with corynebacterium or escherichia bacteria as industrial microbes. Experiments prove a fragment with promoter activity from SEQ ID NO:1 has the activity higher than that of a trc promoter (SEQ ID NO:2).